NRSN Neurosense Therapeutics Ltd
Company Analysis
Latest News
NeuroSense Nears a Canadian Drug Filing for Its ALS Treatment — But Can an $18 Million Company Deliver on the Promise?
Shares of NeuroSense Therapeutics shifted sharply higher this week, touching $0.56 — up 7.5% from the prior close — after the micro-cap biotech announced it...
NeuroSense Nears a Canadian Drug Filing for Its ALS Treatment — But Can an $18 Million Company Deliver on the Promise?
Shares of NeuroSense Therapeutics shifted sharply higher this week, touching $0.56 — up 7.5% from the prior close — after the micro-cap biotech announced it...
🔴 Neurosense Therapeutics is trading 5.4% down today with no clear company-specific explanation
Neurosense Therapeutics is trading 5.4% down at $0.51, with no clear company-specific explanation for the decline. - On August 6, 2026, the company announced...
🟢 Neurosense Therapeutics is trading 11.6% up today on continued optimism for its ALS drug PrimeC
Neurosense Therapeutics is trading 11.6% up today at $0.58 as momentum continues to build around the company's lead ALS candidate, PrimeC. • The move extends...
🟢 Neurosense Therapeutics is trading 8% up today on ALS drug submission plans and pipeline optimism
Neurosense Therapeutics is trading at approximately $0.56 (up 8%) as the company continues to see positive momentum from its ALS drug candidate, PrimeC. •...
🔴 Neurosense Therapeutics is trading 17% down today in after-hours trading amid thin liquidity
Neurosense Therapeutics is trading at $0.43 (17% down) in after-hours trading as the sharp move appears driven by low-liquidity volatility rather than a fresh...
🟢 Neurosense Therapeutics is trading 11.4% up today amid biotech sector strength and risk-on mood
Neurosense Therapeutics is trading 11.4% up today at $0.52, benefiting from a broader risk-on mood and a strong session for biotech shares. • The stock is...
🟢 Neurosense Therapeutics is trading 6.21% up today amid broader risk-on market sentiment
Neurosense Therapeutics is trading at $0.50 (+6.21%) despite a lack of fresh company-specific announcements, earnings reports, or regulatory updates. * The...
🔴 Neurosense Therapeutics is trading 5.3% down today amid low-liquidity after-hours volatility
Neurosense Therapeutics is trading at $0.44 (5.3% down) in after-hours trading, slipping back after a modest regular-session rebound. • The decline likely...
🟢 Neurosense Therapeutics is trading 5.3% up today as it rebounds from a late July sell-off
Neurosense Therapeutics is trading at $0.49 (5.3% up) as the stock stages a modest rebound following a steep multi-day decline in late July. • The move...
🔴 Neurosense Therapeutics is trading 9.7% down today as multi-day decline continues without fresh catalysts
Neurosense Therapeutics is trading at $0.43 (down 9.7%) as its multi-day decline continues despite no new company-specific news or catalysts. • The stock has...
🔴 Neurosense Therapeutics is trading 8.9% down today as multi-day slide continues
Neurosense Therapeutics is trading at $0.42 (-8.90%) in pre-market, extending a recent downward trend despite a lack of fresh company-specific catalysts. •...
NRSN Loses Its Footing After Brief Bounce: Can a Sub-Dollar Biotech Find a Floor?
Shares of Neurosense Therapeutics slid 7.4% to $0.44 on August 1, erasing a short-lived bargain-hunting bounce and extending a punishing selloff that has...
🔴 Neurosense Therapeutics is trading 7.6% down today following a $150 million shelf filing and going-concern warning
Neurosense Therapeutics is trading at $0.43 (-7.57%) in after-hours trading, extending a weak stretch following its $0.47 regular-session close on July 31,...
🔴 Neurosense Therapeutics is trading 7.4% down today as potential dilution from $150M securities shelf and going concern warning weigh on shares
• The decline follows NeuroSense Therapeutics' July 30, 2026, filing of a $150 million securities shelf offering, which permits the company to offer various...
🟢 Neurosense Therapeutics is trading 5% up today on bargain-hunting after recent selloff
Neurosense Therapeutics is trading at $0.50 (5% up) as investors engage in bargain-hunting following a series of sharp declines over the past week. • The...
🟢 Neurosense Therapeutics is trading 5% up today on bargain-hunting after recent selloff
Neurosense Therapeutics is trading at $0.50 (5% up) in after-hours trading as bargain hunters step in following a period of sharp declines. • The move extends...
🟢 Neurosense Therapeutics is trading 7.3% up today on bargain-hunting after recent selloff
Neurosense Therapeutics is trading 7.3% up at $0.52 as bargain hunters move in following a period of sharp declines. • The stock hit a low of $0.48 on July...
🟢 Neurosense Therapeutics is trading 5.6% up today on bargain-hunting after a sharp selloff
Neurosense Therapeutics is trading at $0.51 (+5.6%) in pre-market, extending an after-hours rebound from a sharp multi-day selloff that saw shares close at...
🟢 Neurosense Therapeutics is trading 8.3% up today as it rebounds from a sharp multi-day selloff
Neurosense Therapeutics is trading at $0.52 (up 8.3%) in after-hours trading, rebounding from a sharp decline to a $0.48 close on July 29, 2026. * The stock...